NCT02191878 2019-01-16Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular CarcinomaArbutus Biopharma CorporationPhase 1/2 Completed43 enrolled